Search

everythinglearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Diabetes can cause hair thinning, increased hair loss, and changes in hair growth phases.

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

GLP-1RA therapy may increase the risk of hair loss.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Newer GLP-1 drugs like semaglutide may cause hair loss.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Linagliptin may cause hair loss and skin blisters.

Cats can have hypersomatotropism without diabetes, suggesting current diagnosis methods may miss cases.